Orange Book product · Generic (ANDA)
MUPIROCIN
MUPIROCIN CALCIUM
At a glance
Nov 16, 2021
Approved
Generic (ANDA)
Application
BX
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 16, 2021
4 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
MUPIROCIN CALCIUM
Strength
EQ 2% BASE
Dosage form
CREAM
Route
TOPICAL
TE code
BX
Application
ANDA 213053
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MUPIROCIN CALCIUM
- 1997BACTROBANBrand (NDA)
NDA 050746 · GLAXOSMITHKLINE
- 1995BACTROBANBrand (NDA)
NDA 050703 · GLAXOSMITHKLINE
- 2022MUPIROCINGeneric (ANDA)
ANDA 214811 · AMNEAL
- 2022MUPIROCINGeneric (ANDA)
ANDA 212465 · PADAGIS ISRAEL
- 2021MUPIROCINGeneric (ANDA)
ANDA 213076 · ENCUBE
- 2020MUPIROCINGeneric (ANDA)
ANDA 207116 · SUN PHARMA CANADA
- 2013MUPIROCINGeneric (ANDA)
ANDA 201587 · GLENMARK PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
